ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 075,68
0,99%
Dow Jones
38 903,07
0,13%
DAX
18 430,05
1,42%
Brent Oil
83,41
-0,08%
Bitcoin
63 763,77
0,95%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aduro Biotech Inc (ADRO)

  7. Aduro Biotech Inc (ADRO) Actualités

ADRO

Aduro Biotech (ADRO)

Aduro Biotech Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ADRO
DateHeureSourceTitreSymboleSociété
20/06/202315h06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADROAduro Biotech Inc
20/06/202315h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADROAduro Biotech Inc
12/06/202315h42Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:ADROAduro Biotech Inc
01/06/202301h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADROAduro Biotech Inc
09/05/202322h10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADROAduro Biotech Inc
28/04/202323h43Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ADROAduro Biotech Inc
17/04/202322h52Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ADROAduro Biotech Inc
12/04/202322h57Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADROAduro Biotech Inc
10/03/202322h14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ADROAduro Biotech Inc
14/02/202322h34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADROAduro Biotech Inc
10/11/202223h00Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADROAduro Biotech Inc
10/11/202222h01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ADROAduro Biotech Inc
07/06/202222h46Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADROAduro Biotech Inc
24/05/202222h01Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:ADROAduro Biotech Inc
14/04/202222h46Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADROAduro Biotech Inc
17/03/202221h10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADROAduro Biotech Inc
03/03/202222h35Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ADROAduro Biotech Inc
09/11/202123h28Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:ADROAduro Biotech Inc
15/04/202113h41Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADROAduro Biotech Inc
07/04/202122h55Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ADROAduro Biotech Inc
30/03/202123h27Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:ADROAduro Biotech Inc
05/11/202023h00Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ADROAduro Biotech Inc
15/10/202023h17Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ADROAduro Biotech Inc
05/10/202015h00GlobeNewswire Inc.Chinook Therapeutics Closes Merger with Aduro Biotech and Completes $115 Million Private Placement FinancingNASDAQ:ADROAduro Biotech Inc
01/10/202022h05GlobeNewswire Inc.Aduro Biotech Stockholders Approve Merger Agreement with Chinook TherapeuticsNASDAQ:ADROAduro Biotech Inc
26/08/202022h07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ADROAduro Biotech Inc
24/08/202012h10Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:ADROAduro Biotech Inc
18/08/202022h48Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ADROAduro Biotech Inc
03/08/202022h05GlobeNewswire Inc.Aduro Biotech Provides Business Update and Reports Second Quarter 2020 Financial ResultsNASDAQ:ADROAduro Biotech Inc
24/06/202014h15GlobeNewswire Inc.Aduro Biotech Announces First Patient Dosed in Phase 1 Study of BION-1301 in IgA NephropathyNASDAQ:ADROAduro Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:ADRO

Dernières Valeurs Consultées

EU
SGO
Cie de SaintGobain
SPI
SP500
S&P 500
NASDAQ
GOOGL
Alphabet
EU
ACA
Credit Agricole
EU
MC
Lvmh Moet Hennessy Louis...
EU
CS
Axa
NYSE
MCD
McDonalds
EU
RNO
Renault
EU
PX1
CAC 40
EU
RI
Pernod Ricard
EU
VIV
Vivendi
EU
VK
Vallourec
NASDAQ
AMZN
Amazon.com
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés